For Ozempic, the antidiabetic formulation of the same molecule, the FDA says it should only be used during pregnancy if the potential benefit outweighs the risks, which can include fetal abnormalities and miscarriage
And the access implications are enormous
The drug, marketed as Wegovy for obesity and Ozempic for diabetes, has also transformed the prospects of Novo Nordisk
others charge separately for each service
By leveraging its dual hormonal action, appetite-suppressing properties, metabolic enhancements, and robust clinical efficacy, Tirzepatide offers a valuable option for individuals struggling with obesity and related metabolic conditions
It does not have the GIP receptor activity that gives tirzepatide its edge